Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
4
|
|
Patent #:
|
|
Issue Dt:
|
08/16/2005
|
Application #:
|
10120508
|
Filing Dt:
|
04/05/2002
|
|
Publication #:
|
|
Pub Dt:
|
10/09/2003
| | | | |
|
Inventors:
|
Alan M. Fogelman, Mohamad Navab
|
|
Title:
|
G-TYPE PEPTIDES TO AMELIORATE ATHEROSCLEROSIS
|
|
|
Assignment:
1
|
|
|
|
|
|
|
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) |
| 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980 |
| BETHESDA, MARYLAND 20892-7980 |
|
|
|
|
| DIRECTOR, DEITR |
| NIH, 6705 ROCKLEDGE DRIVE, SUITE 310 |
| MSC 7980 |
| BETHESDA, MD 20892-7980 |
|
|
|
Assignment:
2
|
|
|
|
|
|
|
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE
|
|
|
|
|
|
|
|
|
| NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) |
| 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980 |
| BETHESDA, MARYLAND 20892-7980 |
|
|
|
|
| DIRECTOR, DEITR |
| NIH, 6705 ROCKLEDGE DRIVE, SUITE 310 |
| MSC 7980 |
| BETHESDA, MD 20892-7980 |
|
|
|
Assignment:
3
|
|
|
|
|
|
|
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) |
| 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980 |
| BETHESDA, MARYLAND 20892-7980 |
|
|
|
|
| DIRECTOR, DEITR |
| NIH, 6705 ROCKLEDGE DRIVE, SUITE 310 |
| MSC 7980 |
| BETHESDA, MD 20892-7980 |
|
|
|
Assignment:
4
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 1111 FRANKLIN STREET, 12TH FLOOR |
| OAKLAND, CALIFORNIA 94607 |
|
|
|
|
| QUINE INTELLECTUAL PROPERTY LAW GROUP PC |
| TOM HUNTER |
| P.O. BOX 458 |
| ALAMEDA, CA 94501 |
|
|
Search Results as of:
05/05/2024 02:01 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
